ARTICLE | Company News
Antares, Teva sales and marketing update
May 10, 2010 7:00 AM UTC
Antares received a $500,000 sales milestone payment under a 2006 deal granting Teva exclusive U.S. marketing rights to the Tev-Tropin Tjet Injector system, a needle-free injectable formulation of the...